The Onco'Zine Brief
with Peter Hofland, Ph.D
# Syndicated in 5 of the top 10 Major US Markets
National Advertising
- About the Host
- UK Health Radio™ - The world's no. 1 'Talk Health' radio with +1.2M listeners.
- PRX | Public Radio Exchange - a non-profit web-based platform for digital distribution, review, and licensing of radio programs
- ContentDepot® (summer/fall 2022) - Public radio’s (NPR) national program distribution platform
- New York WGHT 1500/98.3 Mon 12-1pm
- Chicago WCKG 1530/102.3 Wed 2-3 pm
- San Francisco KTRB 860 Sun 6-7 pm
- Atlanta WWWE 1100 Wed 8-9 am
- Boston WCAP 980 Thu 11am -12 pm
- Los Angeles (Riverside /San Bernadino) KCAA 1050/102.3/106.5 Wed 4-5 pm
- Houson KNTH 1070 Sun 3-4 pm
- Phoenix KFNN 1510/105.3 Sun 1-2 pm
- :60 advertising spots in the weekly show, aired on all 9 radio stations
- Monthly press release with show/program information
- Exposure weekly to 5 out of 10 of the major US media markets
- Show promo mentions
- Naming rights
- Open/Close Billboard
- Naming rights
- Co-branded pertinent information with 100% Share of Voice (SOV) in an enduring and engaging format (“Brought to You By... ” or "Made Possible by..." tagline (2 - 3 sentences, maximum 80 words and email/web address)
- Upload and distribution via sponsor’s online media networks
- Download or playback
- High interest/timely content
- Show promo mentions
- Robust traffic-driving audience generation
- Social Media promotion
- Transcripts for white paper
- Show promo mentions
Peter Hofland, Ph.D., the publisher and executive editor of Onco'Zine and ADC Review | Journal of Antibody-drug Conjugates, is also the host of The Onco'Zine Brief, a radio radio broadcast and podcast production about cancer, cancer diagnosis, treatment and prevention. In The Onco'Zine Brief Hofland turns complex clinical, scientific and medical information into easy-to-understand concepts. Using the same approach, Hofland is also a frequent keynote speaker and workshop leader.
About The Onco'Zine Brief
Now it its 4th year with nearly 100 episodes The Onco'Zine Brief discusses the latest developments about cancer, cancer treatment, diagnoses and prevention.
The program reaches between 5 and 6 million monthly listeners and is syndicated in the United States, the United Kingdom and Europe and is available worldwide via iHeart Radio, iTunes, Spreaker, Stitcher, Spreaker and most podcast distribution networks. The program is also made available via:
Planned additional Syndication Details
Staring in the late summer of 2022, The Onco’Zine Brief will be heard each week on 8 stations (6AMs and 3FMs) in 5 of the top 10 US radio markets reaching up to 55 million people. In addition to their broadcasts, all stations also stream online and through all the streaming apps. This includes:
Following the launch via the above-mentioned broadcast stations, National sponsors of The Onco’Zine Brief will receive the following:
Commercial Broadcasters (8 stations)
Branded endorsement (Podcast networks and Public Radio broadcasters):
Show Description
The Onco'Zine Brief is an interview and discussion program covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The program is a sponsor-supported broadcastr/podcast for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. In the United States the program is distributed via PRX | Public Radio Exchange. The program is also heard each week on 9 broadcast stations (6 AMs and 3 FMs) in 5 of the top 10 US radio markets
To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.
Call to Action
Become a sustaining member of The Onco'Zine Brief
